Business · 31/08/2021
FDA Revokes Emergency Use Authorization for COVID-19 Diagnostic Test
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for the Curative SARS-Cov-2 Assay, a COVID-19 diagnostic test, due to a request from the test manufacturer, Curative Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →